10x Genomics, Inc. Operating Lease Cost
10x Genomics, Inc. (TXG) reported Operating Lease Cost of $12.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-02-13
- 10x Genomics, Inc. operating lease, cost for the quarter ending 2021-12-31 was $2.60M, a 13.04% increase year-over-year.
- 10x Genomics, Inc. operating lease, cost for the quarter ending 2021-09-30 was $2.60M, a 23.81% increase year-over-year.
- 10x Genomics, Inc. operating lease, cost for the quarter ending 2021-06-30 was $2.60M, a 23.81% increase year-over-year.
- 10x Genomics, Inc. operating lease, cost for the quarter ending 2021-03-31 was $2.70M, a 42.11% increase year-over-year.
- 10x Genomics, Inc. operating lease, cost for fiscal 2025 was $12.50M, a 0.79% decline from fiscal 2024.
- 10x Genomics, Inc. operating lease, cost for fiscal 2024 was $12.60M, a 7.35% decline from fiscal 2023.
- 10x Genomics, Inc. operating lease, cost for fiscal 2023 was $13.60M, a 3.82% increase from fiscal 2022.
- 10x Genomics, Inc. operating lease, cost for fiscal 2022 was $13.10M, a 24.76% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $12.50M 10-K · filed 2026-02-13 | |||
| 2024-12-31 | $12.60M 10-K · filed 2026-02-13 | |||
| 2023-12-31 | $13.60M 10-K · filed 2026-02-13 | |||
| 2022-12-31 | $13.10M 10-K · filed 2025-02-13 | |||
| 2021-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $5.20M derived: sum of 2 quarters · filed 2024-02-15 | $7.80M derived: sum of 3 quarters · filed 2024-02-15 | $10.50M 10-K · filed 2024-02-15 |
| 2021-09-30 | $2.60M 10-Q · filed 2021-11-05 | $5.20M derived: sum of 2 quarters · filed 2021-11-05 | $7.90M 10-Q · filed 2021-11-05 | $10.20M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $2.60M 10-Q · filed 2021-08-06 | $5.20M 10-Q · filed 2021-08-06 | $7.60M derived: sum of 3 quarters · filed 2023-02-16 | $9.70M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $2.70M 10-Q · filed 2021-05-07 | $5.00M derived: sum of 2 quarters · filed 2023-02-16 | $7.10M derived: sum of 3 quarters · filed 2023-02-16 | $9.20M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $4.40M derived: sum of 2 quarters · filed 2023-02-16 | $6.50M derived: sum of 3 quarters · filed 2023-02-16 | $8.40M 10-K · filed 2023-02-16 |
| 2020-09-30 | $2.10M 10-Q · filed 2021-11-05 | $4.20M derived: sum of 2 quarters · filed 2021-11-05 | $6.10M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $2.10M 10-Q · filed 2021-08-06 | $4.00M 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $1.90M 10-Q · filed 2021-05-07 |